Surgical site infections in Italy;Le infezioni del sito chirurgico in Italia

Infezioni in Medicina

Volumn 17, Issue 4, 2009, Pages 205-218

  De Werra, Carlo ^a   Schiavone, Daniela ^a   Di Micco, Rosa ^a   Triassi, Maria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Kir Nos; Surgical prophylaxis; Surgical site infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; GRAMICIDIN; IMIPENEM; LINEZOLID; MEROPENEM; METRONIDAZOLE; NEOMYCIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TEICOPLANIN; TIGECYCLINE; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

CONTINUOUS INFUSION; DISEASE CONTROL; HOSPITAL INFECTION; HUMAN; ITALY; MORBIDITY; POSTOPERATIVE INFECTION; PREVENTIVE MEDICINE; PROPHYLAXIS; REVIEW; RISK FACTOR; SURGICAL INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; COST SAVINGS; CROSS INFECTION; FEMALE; HUMANS; INFANT; INFECTION CONTROL; ITALY; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; SURGICAL WOUND INFECTION;

EID: 77649297459     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Sands K., Vineyard G., Platt R. Surgical site infections occurring after hospital discharge. J. Infect. Dis. 173 (4): 963-970, 1996.
2. Horan T.C., Gaynes R.P., Martone W.J., et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 13 (10): 606-608, 1992.
3. Mangram A.J., Horan T.C., Pearson M.L., et al. The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection. Infect. Control Hosp. Epidemiol. 20: 250-278, 1999.
4. Nichols RL. Preventing surgical sit infections: a surgeon's perspective. Emerg. Infect. Dis. 7: 220-224, 2001.
5. Emory T.G., Gaynes R.P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin. Microbiol. Rev. 6: 428-442, 1993.
6. Cruse P. Wound infection surveillance. Rev Infect Dis. 3 (4): 734-737, 1981.
7. Leaper D.J., van Goor H., Reilly J., et al. Surgical site infection - a european perspective of incidence and economic burden. Int. Wound J. 1: 247-273, 2004.
8. Boni L., Benevento A., Rovera F, et al. Infective complications in laparoscopic surgery. Surg Infect (Larchmt) 7, (Suppl. 2): 109-111, 2006.
9. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect. Control Hosp. Epidemiol. 20: 725-730, 1999.
10. Di Piro J.T., Martindale R.G., Bakst A., Vacani P.F., Watson P., Miller M.T. Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care. Am. J. Health Syst. Pharm. 55: 777-781, 1998.
11. Whitehouse J.D., Friedman N.D., Kirkland K.B., Richardson W.J., Sexton D.J. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect. Control Hosp. Epidemiol. 23, 4: 183-189, 2002.
12. Hollenbeak C.S., Murphy D., Dunagan W.C., Fraser V.J. Nonrandom selection and the attributable cost of surgical-site infections. Infect. Control Hosp. Epidemiol. 23, 4: 177-182, 2002.
13. Haley R.W., Culver D.H., White J.W., Morgan W.M., Emori T.G., Munn V.P., Hooton T.M. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol. 121 (2): 182-205, 1985.
14. http://www.who.int/csr/resources/publications/ drugresist/WHO-CDS-CSR- EPH-2002-12/en/
15. Barclay L. Improvements needed in infection control, survey suggests. Nursing 28-36, 2007.
16. Belkin N.L. Gowns and drapes for the "level of exposure anticipated". Bull. Am. Coll. Surg. 87: 20-22, 2002.
17. Mitchell D. Antimicrobial gloves are a simple way to reduce MDR nosocomial infections. Reuters Health Information, 2006.
18. Baxter R.L., Baxter H.C., Campbell G.A., et al. quantitative analysis of residual protein contamination on reprocessed surgical instruments. J. Hosp. Inf. 63: 439-444, 2006.
19. Brochard-Lemort C. Standard and recommendations for hospital environmental hygiene. Ann. Biol. Clin. 58: 431-437, 2000.
20. Harbarth S., Sax H., Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J. Hosp. Inf. 54: 258-266, 2003.
21. Astagneau P., Rioux C., Golliot F., Brucker G. Morbidity and mortality associated with surgical site infections: results from the 1997-1999 INCISO surveillance. J. Hosp. Infect. 48: 267-274, 2001.
22. Fiorio M., Marvaso A., Viganò F., Marchetti F. Incidence of surgical site infections in general surgery in Italy. Infection 34: 310-314, 2006.
23. Loo V.G., McLean A.P. Infection control in surgical practice. ACS Surgery, 2004.
24. Lafreniere R., Berguer R., Seifert P.C., et al. Preparation of the operating room. In: Wilmore DW, editor. ACS Surgery. principles and practice 2004. New York, NY: WebMD. 12-13, 2004.
25. Houang E.T., Ahmet Z. Intraoperative wound contamination during abdominal hysterectomy. J. Hosp. Infect. 19 (3): 181-189, 1991.
26. Classen D.C., Evans R.S., Pestotnik S.L., et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med. 326 (5): 281-286, 1992.
27. DiPiro J.T., Cheung R.P., Bowden T.A. Jr., et al. Single dose systemic antibiotic prophylaxis of surgical wound infections. Am. J. Surg. 152 (5): 552-559, 1986.
28. McDonald M., Grabsch E., Marshall C., et al. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust. N. Z. J. Surg. 68 (6): 388-396, 1998.
29. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101 (25): 2916-2921, 2000.
30. Garibaldi R.A., Cushing D. Lerer T. Risk factors for postoperative infection. Am. J. Med. 91 (3 B): 158S-163S, 1991.
31. Perl T.M., Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann. Pharmacother. 32 (1), S7-S16, 1998.
32. Kluytmans J.A., Mouton J.W., Ijzerman E.P., et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171 (1): 216-219, 1995.
33. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep. 44 (RR-12), 1-13, 1995.
34. Bolon M.K., Morlote M., Weber S.G., et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin. Infect. Dis. 38 (10): 1357-1363, 2004.
35. Dodds Ashley E.S., Carroll D.N., Engemann J.J., et al. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 38 (11): 1555-1560, 2004.
36. Noskin G.A., Rubin R.J., Schentag J.J., et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch. Intern. Med. 165 (15): 1756-1761, 2005.
37. Barlam T.F, Kasper D.L. Common contamination of gloves and gowns with Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci during routine patient care. Access Medicine from MacGraw-Hill, 2008] [SHEA 19th Annual Scientific Meeting. March, 2009.
38. Stevens D.L., Herr D., Lampiris H., et al. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34: 1481, 2002.
39. Florescu I., Beuran M., Dimov R., et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with MRSA or VRE: a phase 3, multicentre, double-blind, randomized study. J. Antimicrob. Chemother. 62 (Suppl.1) i17-i28, 2008.
40. Concia E. Nuovi approcci terapeutici nelle infezioni della cute e dei tessuti molli e nelle infezioni intra-addominali. XIII Congresso Nazionale FADOI, 2008.
41. Olsen M.A., Lefta M., Dietz J.R., et al. Risk factors for surgical site infection after major breast operation. J. Am. Coll. Surg. 207 (3): 326-335, 2008.
42. Campbell D.A. Jr., Henderson W.G., Englesbe M.J. Surgical site infection prevention: the importance of operative duration and blood transfusion results of the first american college of surgeons-national surgical quality improvement program best practices initiative. J. Am. Coll. Surg. 207: 810-820, 2008.
43. Suehiro T., Hirashita T., Araki S., et al. Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepatogastroenterology 55 (86-87): 1636-1639, 2008.
44. Meakins J.L., Masterson B.J. Principle and practice on prevention of postoperative infection [online]. 2005 [cited 2009 April 3]. Available from: URL: http://www.facs.org/members/acs-surgery.html
45. Itani K.M.F., Wilson S.E., Awad S.S., et al. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N. Engl. J. Med. 355: 2640-2651, 2006.
46. Lowenfels B.A. Soft tissue infection: surgical drainage is key. Arch. Surg. 141: 850-856, 2006.
47. Storch M., Scalzo H., Van Lue S., et al. Physical and functional comparison of coated VYCRIL* plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VYCRIL* suture (coated polyglactin 910 suture). Surg. Inf. 3 (Suppl. 1): 65-67, 2002.
48. Storch M., Perry L.C., Davidson J.M., et al. A 28-day study of the effect of coated VYCRIL* plus antibacterial suture (coated polyglactin 910 suture with triclosan) on wound healing in Guinea pig linear incisional skin wounds. Surg. Inf. 3 (Suppl. 1): 89-98, 2002.
49. Ming X., Nichols M., Rothenburger S. In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture. Surg. Infect. (Larchmt). 8 (2): 209-214S, 2007.
50. Fleck T., Moidl R., Blacky A., et al. Triclosan-Coated sutures for reduction of sternal wound infections: economic considerations. Ann. Thorac. Surg. 84, 232-236, 2007.
51. Otten J.E., Wiedmann-Al-Ahmad M., Jahnke H., Pelz K. Bacterial colonization on different suture materials. A potential risk for intraoral dentoalveolar surgery. J. Biomed. Mat. Res. 74B, 1: 627-635, 2005.
52. Rozzelle C.J., Leonardo J., Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J. Neurosurg. Pediatrics. 2: 111-117, 2008.
53. Steinman M.A., Ranji S.R., Shojania K.G., et al. Interventions to reduce unnecessary antibiotic prescribing. A systematic review and quantitative analysis. Med. Care. 46, 8, 847-862, 2008.